発射分子が保存された心不全: 臨床医が知っておくべきすべて
Patricia Campbell1, Frans H Rutten2, Matthew My Lee3
1Department of Cardiology, Southern Trust, Craigavon Area Hospital, Portadown, UK.
Lancet (London, England)
|February 17, 2024
まとめ
発射分子が保存された心不全 (HFpEF) は,しばしば肥満と糖尿病に関連して,多くの人に影響を与える複雑な状態です. このレビューは,HFpEFの診断と管理を臨床医に簡素化し,SGLT2阻害剤のような併発症と新しい治療法を強調しています.
科学分野:
- 心臓病科
- 内科 医学
背景:
- 心臓機能不全と保存されたエジェクション分数 (HFpEF) は,すべての心臓機能不全症例の少なくとも半分を占める,増大する臨床的課題です.
- 人口の高齢化や 肥満や糖尿病などの 併発性疾患の増加により 診断される傾向があります
- HFpEFは複雑な病理生理学,多様な疫学,そして進化する治療戦略を提示しています.
研究 の 目的:
- 最近の臨床試験,疫学データ,ガイドラインの勧告を統合して,HFpEFに関する最新の洞察を統合する.
- 医療従事者,一般医,非専門医の心臓科医に 実践的な指導を提供すること.
- HFpEFの診断と管理を簡素化し,併発症と現在の治療に重点を置く.
主な方法:
- 最近の臨床試験と疫学研究の文献合成.
- HFpEFの診断と管理に関する現在のガイドラインのレビュー
- 非薬学的および薬学的治療戦略に重点を置く.
主要な成果:
- HFpEFは様々な原因と症状を持つ複雑な症候群です.
- 管理には併発症に対処し,最新の治療法を使用する必要があります.
- SGLT2阻害剤は,薬理学的治療における重要な進歩を表しています.
結論:
- HFpEFの診断と管理は困難ですが,ますます理解されています.
- 効果的な患者のケアには 実用的で根拠に基づいた勧告が不可欠です
- 新薬剤の導入と併発症の管理は,HFpEFの改善に不可欠です.
関連する概念動画
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:22Heart Failure Drugs: β-Blockers
340
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340
01:26Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
01:17Imaging Studies for Cardiovascular System I:Echocardiography
331
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
331
01:22Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381